Company Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Business Summary
Number of employees: 579
Managers
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Director/Board Member | 59 | 22-10-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 97,235,316 | 46,097,791 ( 47.41 %) | 0 | 47.41 % |
Company contact information
![address Myovant Sciences Ltd.(MYOV)](https://cdn.zonebourse.com/static/address/31698733.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+48.54% | 56.61B | |
+36.75% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B |